Want to contact a Clozaril attorney in Washington, DC?...Get a free case evaluation from one of our Clozaril attorneys in Washington, DC now.

Clozaril - News Articles

U.S. PSYCH: Atypical Antipsychotic Medication Cuts Behavioral Symptoms in Autism
Apr 26, 2007
Psychiatric Times, NY -
SAN FRANCISCO, April 25 -- While the behavioral symptoms of autism have been treated with a wide spectrum of medications, atypical antipsychotics may be the most effective drug class.So said Lawrence D. Scahill, Ph.D., of Yale University, in a presentation here at the U.S. ...
U.S. PSYCH: Vigilance Still Necessary for Atypical Antipsychotics
Apr 26, 2007
Psychiatric Times, NY -
SAN FRANCISCO, April 25 -- Atypical antipsychotic medications have improved adverse-event profiles compared with the older generation of antipsychotics, but careful attention to major side effects is still required. The overall medication plan should address the major side ...
USPSYCH: New Definitions on Tap for Mixed Manias
Thursday, April 26, 2007
Psychiatric Times, NY -
risperidone (Risperdal) or ziprasidone (Geodon) as initial treatment with olanzapine (Zyprexa) and clozapine (Clozaril) as alternate choices. Nonresponders should be put on an alternate monotherapy.Stage two, for patients who get only partial response is to try ...
Article : Acadias CNS Pipeline Propels Growth Genetic Engineering News - Biotechnology from Bench to Business
Apr 13, 2007
Genetic Engineering News (press release), NY -
Acadia’s second schizophrenia candidate is ACP-104, or N-desmethylclozapine, the major metabolite of clozapine, an atypical drug. It is being developed as a novel, stand-alone therapy. The drug combines an atypical antipsychotic efficacy profile with the potential benefit of enhanced cognition, thereby ...
Radio New Zealand News : Latest News : 200704011518 : Warning on prescribing of Clozapine
Mar 31, 2007
Radio New Zealand, New Zealand -
The Intensive Medicines Monitoring Programme says one person has died from an acute blood disorder as a result of using Clozapine. It says four other deaths were caused by another side effect, severe constipation.Pete Ellis, from the University of Otago and ...
Outcomes of Obese, Clozapine-Treated Inpatients With Schizophrenia Placed on a Six-Month Diet and Physical Activity Program -- Wu et al. 58 (4): 544 -- Psychiatr Serv
Apr 5, 2007
Psychiatric Services (subscription) -
OBJECTIVE: Patients with schizophrenia treated with clozapine often gain weight. This study evaluated the effects of dietary control and physical activity among obese inpatients with schizophrenia being treated with clozapine. METHODS: Fifty-three clozapine-treated obese patients with schizophrenia in a veterans ...
Possible Delayed Speech Acquisition With Clozapine Therapy During Pregnancy and Lactation -- Mendhekar 19 (2): 196 -- J Neuropsychiatry Clin Neurosci
Apr 12, 2007
Journal of Neuropsychiatry (subscription) -
SIR: Most of the study by Ernst and Goldberg 1 reported perinatal outcome with clozapine therapy with no focus on neurodevelopment. Here, I report a case of a woman with schizophrenia who continued clozapine treatment throughout her 9 months of ...
Amarin Appoints Paul F. Duffy to New Position of President - U.S. Commercial Operations
Apr 5, 2007
Drug Newswire (press release), CT -
At Alamo, he created a fully integrated commercial pharmaceutical company to market Fazaclo, a reformulation of Novartis' anti-psychotic drug, Clozaril. ...
FresnoBee.com: Local: Lawsuits filed over fatal overdose
Monday, April 16, 2007
Fresno Bee (subscription), CA -
13 and 14 Gremminger was given 300 milligrams of Clozaril. Spitz wrote that the combination of both drugs was dangerous. The doses were given despite a note in his admitting report telling doctors that Gremminger had stopped taking Clozaril for about a month before he arrived ...
The American Journal of Psychiatry -- Sign In Page
Monday, April 02, 2007
Am J Psychiatry (subscription) -
Rosenheck RA, Swartz MS, Perkins DO, Keefe RS, Davis CD, Severe J, Hsiao JK, the CATIE Investigators: Effectiveness of clozapine versus olanzapine, ...
PharmaLive: ACADIA Pharmaceuticals' Schizophrenia Programs to Be Presented at the 2007 International Congress on Schizophrenia Research
Mar 29, 2007
PharmaLive.com (press release), PA -
In contrast, clozapine impaired performance in both these assays. The pro-cognitive effects of ACP-104 were shown to be dependent upon M1 muscarinic activity. These findings suggest that ACP-104 will have a superior clinical profile with activity against all symptom domains (positive, ...
Cost-Effectiveness of Schizophrenia Pharmacotherapy -- SOUMERAI and LAW 164 (4): 678 -- Am J Psychiatry
Monday, April 02, 2007
Am J Psychiatry (subscription) -
To The Editor: The study by Robert A. Rosenheck, MD and colleagues represents a large and ambitious attempt to study the cost-effectiveness of pharmacotherapy for the treatment of schizophrenia (1). The authors acknowledge the caveats for policy making. However, we are concerned ...
Dr. Rosenheck and Colleagues Reply -- ROSENHECK et al. 164 (4): 678 -- Am J Psychiatry
Monday, April 02, 2007
Am J Psychiatry (subscription) -
To The Editor: Stephen Soumerai and Michael R. Law urge appropriate caution for antipsychotic formulary policy development, but their letter implicitly endorses maintenance of the current status quo. Second-generation antipsychotics have captured 90% of the market due, in part, to ...
Arch Gen Psychiatry -- Abstract: Second-Generation Antipsychotic Agents in the Treatment of Acute Mania: A Systematic Review and Meta-analysis of Randomized Controlled Trials, April 2007, Scherk et al. 64 (4): 442
Monday, April 02, 2007
Archives of General Psychiatry -
Study Selection The abstracts, titles, and index terms of studies were searched using the following key words: aripiprazole, amisulpride, clozapine, olanzapine, quetiapine, risperidone, ziprasidone, and zotepine in conjunction with mania, manic, and bipolar. Data Extraction  Data on efficacy, global ...
JAMA -- Sign In Page
Mar 27, 2007
Journal of American Medical Association (subscription), IL -
"Clinically, clozapine did wonderful things, but drug companies had no idea why," said Snyder. Other AAPDs were subsequently manufactured that mimicked ...
Clozapine Benefits Outweighs Risk: MoH
Mar 31, 2007
newswire.co.nz, New Zealand -
The Ministry of Health says the benefits of using of the anti-psychotic drug Clozapine outweigh the risks, despite a review showing five people have died after being prescribed the drug.The Intensive Medicines Monitoring Program says after taking the drug, one patient died from an ...
Radio New Zealand News : Latest News : 200704011518 : Warning on prescribing of Clozapine
Mar 31, 2007
Radio New Zealand, New Zealand -
Health professionals are being urged to monitor patients on a schizophrenia drug after a review found that five people have died from its side effects. The Intensive Medicines Monitoring Programme says one person has died from an acute blood disorder as a result of using ...
Amarin Appoints Paul F. Duffy to New Position of President - U.S. Commercial Operations
Tuesday, April 03, 2007
Earthtimes.org -
At Alamo, he created a fully integrated commercial pharmaceutical company to market Fazaclo, a reformulation of Novartis' anti-psychotic drug, Clozaril. ...
globeandmail.com: Health
Feb 26, 2007
Globe and Mail, Canada -
A fourth in this class, clozapine (Clozaril), was not studied. But because it is in the same family, Health Canada included it in its warning about the ...
Effects of Antipsychotic Medications on Psychosocial Functioning in Patients With Chronic Schizophrenia: Findings From the NIMH CATIE Study -- Swartz et al. 164 (3): 428 -- Am J Psychiatry
Feb 28, 2007
Am J Psychiatry (subscription) -
Clozapine was included for patients who chose this pathway after discontinuing phase 1 due to inefficacy; all other patients received another second-generation antipsychotic. Psychosocial functioning was assessed using the Quality of Life Scale. RESULTS: Psychosocial functioning modestly improved for the ...
Want to contact a Clozaril attorney in Washington, DC?...Get a free case evaluation from one of our Clozaril attorneys in Washington, DC now.

Pages: Previous   1   2   3   4   5   6   7   8   9   Next

AddThis Social Bookmark Button

 

Need A Clozaril Attorney?

First Name Last Name Email Address State
Has Your Health Been Negatively Affected?

Please Describe the Injury
Click to Ask a Question

Your Friend's Email Address

Your Email Address

Type a Message (optional)


 

Need A Clozaril Lawyer?

First Name Last Name Email Address State
Has Your Health Been Negatively Affected?

Please Describe the Injury
Click to Ask a Question

 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Clozaril Case - Submit Your Information Below

Do you need legal assistance with your Clozaril case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * DrugWatch: Clozaril Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.